Position in TRVI
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$71,597
+$29,771 QoQ
Shares Held
3,839
+9.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#174
of 216 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NISA INVESTMENT ADVISORS, LLC holds $78,277,664 across 265 Biotechnology names. TRVI ranks #71 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
56,455 | $28,042,892 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
19,412 | $12,104,158 | |
| 3 | TECH |
BIO-TECHNE Corp
|
68,452 | $4,836,133 | |
| 4 | INCY |
Incyte Corp
|
26,479 | $3,001,659 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,139 | $2,751,113 | |
| 6 | DFTX |
Definium Therapeutics, Inc.
|
48,369 | $2,275,277 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
6,111 | $2,045,901 | |
| 8 | EXEL |
Exelixis, Inc.
|
36,758 | $2,000,002 |
All Filings in TRVI
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $71,597 | 3,839 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $41,826 | 3,506 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $11,255 | 899 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $1,546 | 169 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $924 | 169 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $1,063 | 169 | Shares | Sole | 2025-04-30 | |
| 2024-09-30 | $280 | 84 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $8 | 3 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $10 | 3 | Shares | Sole | 2024-05-02 | |
| No filing history on record for this holder in this stock. | ||||||